Order Entry
ContactUsLinkComponent
EnzyFluo™ Farnesyltransferase Inhibitor Screening Kit
EnzyFluo™ Farnesyltransferase Inhibitor Screening Kit
# de catalogue 77441-686
Fournisseur:  BIOASSAY SYSTEMS
New Product
Numéro CAS:  
FARNESYLTRANSFERASE INHIBITOR KIT
EnzyFluo™ Farnesyltransferase Inhibitor Screening Kit
# de catalogue 77441-686
Fournisseur:  BIOASSAY SYSTEMS
New Product
Numéro CAS:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Spécifications

  • Description:
    EnzyFluo™ farnesyltransferase inhibitor screening kit
  • Size:
    400 tests
  • Cat. no.:
    77441-686

Spécifications

A propos de cet article

For high-throughput screening of FTase inhibitors and evaluation of drug modulators.

  • Safe and non-radioactive assay
  • Homogeneous and convenient
  • 'Mix-incubate-measure' type assay
  • No wash and reagent transfer steps are involved
  • High-throughput
  • A Z - factor of 0.8 and higher is routinely observed in a 384-well format
  • Can be readily automated to assay thousands of samples per day

Farnesyltransferase (FTase, EC 2.5.1.58) catalyzes the transfer of a farnesyl group from farnesyl pyrophosphate to the cysteine residue of the C-terminus of target proteins. When not properly regulated, farnesylated proteins, including the Ras superfamily of small GTPases, can lead to developmental disorders and cancer. Simple, direct and high-throughput inhibitor screening assays find wide applications for oncology research.

BioAssay Systems EIFT-400 assay kit provides a convenient fluorimetric method to screen for potential FTase inhibitors. In this assay, FTase reacts with farnesyl pyrophosphate and a dansyl-peptide substrate with measurable fluorescence at λem/ex = 340/550 nm. Inhibition is determined by the decrease in fluorescence.

Customers Who Bought This Also Bought